Research Validates

 
News Articles for Research Validates top ^
All Claims Found to be Valid PLANO, Texas , July 2, 2014 /PRNewswire/ -- ContentGuard Holdings, Inc. ("ContentGuard"), a subsidiary of Pendrell Corporation (NASDAQ: PCO) , announced today that the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued final written decisions on June 26, 2014 and July 1, 2014 finding valid all claims of the ContentGuard digital rights management (DRM) patents at issue.
Sign-up for ContentGuard Prevails In All Patent Trials Challenging The Validity Of Its Digital Rights Management Patents investment picks
Study Achieved Primary Endpoint of Predicting Recurrence after Surgery and Reconfirmed Original Adverse Pathology Endpoint from Published UCSF Validation Study Data Submitted for Presentation at Medical Meeting Later this Year REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Positive Topline Results of Additional, Large Independent Validation Study of Oncotype DX® Prostate Cancer Test with Multiple Clinical Endpoints investment picks
2014/8/14
Today 3M Library Systems sets the library industry security standard by becoming Payment Application Data Security Standard (PA-DSS) validated for fines and fees collection.
Sign-up for 3M Library Systems Receives Payment Application Data Security Standard Validation investment picks
CBD Energy Limited (NASDAQ: CBDE) validates the assertions of Goldman Sachs’ analyst Brian Lee that the U.S. residential solar sector will see dramatic growth over the next two years, as reported in the financial press on June 17.
Sign-up for Global Solar Installations Leader CBD Energy Validates Goldman Estimates investment picks
2014/9/3
ValidSoft is World's First Security Software Company to Achieve Four 'EuroPriSe' Privacy Seals LONDON , Sept.
Sign-up for ValidSoft Receives Unprecedented 4th European Privacy Seal for its Zero Latency Correlation (Valid-ZLC®) Technology investment picks
2014/8/11
Court Denies Apple Motion Alleging Indefiniteness in Markman Ruling ZEPHYR COVE, Nev.
Sign-up for Court Ruling Prohibits Apple From Challenging Validity Of 16 VirnetX Patent Claims In New Patent Infringement Suit investment picks
Additional Data Acceptances Include Multiple Oncotype DX® Studies in Breast and Renal Cancers REDWOOD CITY, Calif.
Sign-up for Genomic Health Announces Presentation of Positive Results from Latest Prostate Cancer Clinical Validation Study at the European Society for Medical Oncology (ESMO) 2014 Congress investment picks
Qualstar Corporation (NASDAQ: QBAK), a manufacturer of data security and archive storage solutions and high efficiency power supplies, announces the inclusion of Crossroads Systems ReadVerify Appliance (RVA) in Qualstar’s storage solutions product portfolio.
Sign-up for Qualstar Announces the Crossroads ReadVerify® Appliance with New ArchiveVerify™ Media Validation Feature investment picks
MINNEAPOLIS , June 30, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, reported that in the recently updated Overactive Bladder (OAB) treatment guideline from the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), Percutaneous Tibial Nerve Stimulation (PTNS) is listed as a recommended third-line therapy.
Sign-up for AUA/SUFU Validate Peripheral Tibial Nerve Stimulation (PTNS) For The Treatment Of Overactive Bladder In Newly Published Guidelines investment picks
2014/6/25
LEXINGTON, Massachusetts , June 25, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Judge Stanley R.
Sign-up for Vyvanse® Patents Found to Be Infringed and Valid by U.S. District Court investment picks
First-and-Only Carrier Class Microwave Solution rated FIPS 140-2 Level 2 SANTA CLARA, Calif.
Sign-up for Aviat Networks Achieves FIPS 140-2 Level 2 Validation for Microwave Radio Security investment picks
SAN DIEGO, July 14, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX) announced today the issuance of a new patent, US 8,734,384, from the United States Patent and Trademark Office (USPTO). The patent covers the biphasic pressure profile utilized by the company's proprietary DosePro ® Needle-free Delivery System.
Sign-up for Zogenix Announces New Patent Valid Through 2032 For DosePro(R) Needle-Free Delivery System investment picks
2014/7/13
EAST HARTFORD, Conn.
Sign-up for Pratt & Whitney's PurePower® Engine Achieves Nearly 10,000 Hours of Engine Testing Validating Technology Maturity investment picks
Petitions Directed To All Patent Claims Asserted By Macronix In ITC Investigation No.
Sign-up for Spansion Files Multiple Petitions With The U.S. Patent Office Challenging Validity Of Macronix's Patent Claims investment picks
NEW YORK, July 16, 2014 (GLOBE NEWSWIRE) -- Sizmek (Nasdaq:SZMK) today announced the availability of Sizmek Audience Suite, a tool that provides marketers with an integrated view of campaign performance measurements within the Sizmek MDX open ad management platform together with data from either of two leading measurement sources, comScore vCE® or Nielsen Online Campaign Ratings.
Sign-up for New Sizmek Audience Suite Delivers Unified View of Sizmek Performance Metrics With Data From comScore Validated Campaign Essentials(TM) or Nielsen Online Campaign Ratings(TM) investment picks
Hyde Marine, Inc., announces today it will begin using a new ballast water test system, B-box, recently made available from the Royal Netherlands Institute for Sea Research (NIOZ) to help ballast water treatment (BWT) technology companies conduct accurate analysis regarding the concentrations of chemicals or organisms present in ballast water.
Sign-up for Hyde Marine to Provide B-box Ballast Water Treatment Service, NIOZ Testing Protocol to Help Validate System Performance investment picks
2014/8/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135216&ProfileId=051205&sourceType=1 DALLAS, TX --
Sign-up for Paradigm Oil & Gas, Reserve Reports to Validate Assets and Oil Production investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Validates
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Universe  |  Next: Research Vice